Your Vision Our Focus
- Feel free to contact us or follow us
-
-
Afandin has a strong national and international network of life science contacts. This stems from its partners’, Ian Nisbet and Anthony Filippis, combined 50 years plus international business experience and credibility in dealing with pharma, biotech and investment organisations.
Afandin’s mission is to help create companies that can successfully develop new products and technologies that improve health and quality of life.
Partner
Anthony is passionate about biotechnology and technology innovation – he loves it! He has direct experience in assisting established corporates develop, implement and execute their business strategies; also assisting growing organisations to put in place the appropriate processes for success. Anthony has key skills in corporate strategy, project management, and business & corporate development, and has advised numerous organisations on corporate and business strategy, in- and out-licensing of technologies, accessing capital, corporate restructuring, and mergers and acquisitions (M&A).
Anthony received his BSc (Hons.) in biochemistry from La Trobe University and his PhD in biochemistry from The University of Melbourne. He also holds a Master of Business Administration, specialising in entrepreneurship & innovation and new venture creation from La Trobe University.
In his spare time, Anthony enjoys attending his kids’ sporting and extra-curricular activities, watching sport, volunteering in his community and going out for dinner and socialising with family and friends.
Details on Anthony’s professional profile can be seen by visiting his LinkedIn page – please click on the icon below.
Partner
Ian understands the importance of timing. He views his career in biotechnology drug development and commercialisation as wonderful timing. He has participated in, and contributed to, an amazing time in the history of drug discovery and development – monoclonal antibodies, recombinant DNA technology, targeted drugs and cell therapies. He has worked with large, established companies as well as small start-ups, both in Australia and the US. He has led drug development teams, including the teams that developed two FDA-approved drugs. He has led multiple licensing and M&A transactions. He has held executive and board level positions, including CEO and Chairman, and led, managed and mentored a range of scientific and business colleagues.
Ian holds a BSc in biochemistry and microbiology at The University of Melbourne and a PhD in biochemistry from Monash University. He completed the Advanced Management Program at Melbourne Business School, as well as short business and finance courses at Harvard School of Public Health and the Sloan School of Management at MIT.
Outside his professional career Ian collects art, plays an occasional round of golf, and undertakes DIY projects around his home, his beach house and his wife’s café. He also enjoys a broad range of music – mostly listening to CDs (from a vast collection) and attending live concerts, but sometimes playing guitar himself (pretty badly).
Details on Ian’s professional profile can be seen by visiting his LinkedIn page – please click on the icon below.